GlaxoSmithKline (GSK)

Add to Watchlists
Create an Alert
35.25 -0.33  -0.93% NYSE Dec 14, 16:59 Delayed 2m USD

GlaxoSmithKline Enterprise Value:

111.33B for Dec. 13, 2017
View 4,000+ financial data types
Browse...
View Full Chart

GlaxoSmithKline Enterprise Value Chart

Export Data
Save Image
Print Image

GlaxoSmithKline Historical Enterprise Value Data

View and export this data going back to 1976. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
Dec. 13, 2017 111.33B
Dec. 12, 2017 111.18B
Dec. 11, 2017 110.67B
Dec. 8, 2017 110.32B
Dec. 7, 2017 109.51B
Dec. 6, 2017 109.07B
Dec. 5, 2017 109.56B
Dec. 4, 2017 109.91B
Dec. 1, 2017 110.69B
Nov. 30, 2017 110.05B
Nov. 29, 2017 111.06B
Nov. 28, 2017 112.17B
Nov. 27, 2017 111.26B
Nov. 24, 2017 110.00B
Nov. 22, 2017 110.05B
Nov. 21, 2017 109.44B
Nov. 20, 2017 110.20B
Nov. 17, 2017 110.05B
Nov. 16, 2017 110.37B
Nov. 15, 2017 109.61B
Nov. 14, 2017 109.86B
Nov. 13, 2017 110.13B
Nov. 10, 2017 110.64B
Nov. 9, 2017 111.80B
Nov. 8, 2017 113.55B
   
Nov. 7, 2017 111.92B
Nov. 6, 2017 112.71B
Nov. 3, 2017 112.73B
Nov. 2, 2017 112.24B
Nov. 1, 2017 112.86B
Oct. 31, 2017 113.42B
Oct. 30, 2017 114.06B
Oct. 27, 2017 112.93B
Oct. 26, 2017 113.84B
Oct. 25, 2017 117.75B
Oct. 24, 2017 123.38B
Oct. 23, 2017 123.73B
Oct. 20, 2017 124.27B
Oct. 19, 2017 124.91B
Oct. 18, 2017 124.69B
Oct. 17, 2017 124.24B
Oct. 16, 2017 124.32B
Oct. 13, 2017 124.69B
Oct. 12, 2017 124.71B
Oct. 11, 2017 124.32B
Oct. 10, 2017 124.12B
Oct. 9, 2017 123.68B
Oct. 6, 2017 123.70B
Oct. 5, 2017 123.82B
Oct. 4, 2017 124.17B

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Enterprise Value

Click "Learn More" below to see how YCharts calculates Enterprise Value.

Enterprise Value (EV) is a valuation metric alternative to traditional market capitalization that reflects the market value of an entire business. Like market cap, EV is a measure of what the market believes a company is worth. Enterprise value captures the cost of an entire business, including debt and equity. It is a sum of claims of all preferred shareholders, debt holders, security holders, common equity holders, and minority shareholders - unlike market cap, which only captures the total value of common equity securities.

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Learn More

Advertisement

GSK Enterprise Value Benchmarks

Benchmarks
AstraZeneca 99.35B
Celgene 87.70B
Johnson & Johnson 402.81B

GSK Enterprise Value Range, Past 5 Years

Minimum 109.07B Dec 06 2017
Maximum 160.97B Apr 29 2014
Average 133.79B

GSK Enterprise Value Excel Add-In Codes

  • Metric Code: enterprise_value
  • Latest data point: =YCP("GSK", "enterprise_value")
  • Last 5 data points: =YCS("GSK", "enterprise_value", -4)

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.